12:00 AM
 | 
Nov 16, 2009
 |  BC Week In Review  |  Company News  |  Deals

Advancell Advanced In Vitro Technologies S.A., BTG deal

BTG returned to Advancell its co-development rights for Acadra acadesine in exchange for an undisclosed potential milestone and royalties. BTG, which gained rights to the nucleoside...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >